Literature DB >> 17520677

Increased HIF1 alpha in SDH and FH deficient tumors does not cause microsatellite instability.

Heli J Lehtonen1, Markus J Mäkinen, Maija Kiuru, Päivi Laiho, Riitta Herva, Ivonne van Minderhout, Pancras C W Hogendoorn, Cees Cornelisse, Peter Devilee, Virpi Launonen, Lauri A Aaltonen.   

Abstract

Germline mutations in nuclear genes encoding mitochondrial enzymes fumarate hydratase (FH) and succinate dehydrogenase (subunits SDHB/C/D) have been implicated in the development of tumor syndromes referred to as hereditary leiomyomatosis and renal cell cancer (HLRCC) and hereditary paragangliomatosis (HPGL), respectively. FH and SDH are operating in the tricarboxylic acid cycle (the TCA cycle, the Krebs cycle). In the FH and SDH deficient tumors, accumulation of the substrates, fumarate and succinate, has been shown to cause stabilization of hypoxia inducible factor 1 alpha (HIF1 alpha). According to recent studies, HIF1 alpha could contribute to the hypoxia induced genomic instability seen in many cancers, through repression of mismatch repair (MMR) protein MSH2. In this study, in agreement with previous works, we found HIF1 alpha to be moderately or highly stabilized in 67% (16/24) and 77% (48/62) of HLRCC tumors and SDHB/C/D paragangliomas (PGL) and pheochromocytomas (PHEO), respectively. In addition, a set of 54 other familial and nonfamilial PGLs/PHEOs were studied. Moderately or highly stabilized HIF1 alpha was present in 68% (26/38) of the PGLs but in PHEOs (n = 16) no such pattern was observed. We then analyzed the suggested link between HIF1 alpha stabilization and MSH2 repression, in HLRCC and HPGL tumor material. No microsatellite instability (MSI) or lack of MSH2 expression was, however, observed. Thus we failed to provide in vivo evidence for the proposed link between HIF1 alpha stabilization and functional MMR deficiency, in TCAC deficient tumors. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17520677     DOI: 10.1002/ijc.22819

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  Alterations of oxidative phosphorylation in meningiomas and peripheral nerve sheath tumors.

Authors:  René G Feichtinger; Serge Weis; Johannes A Mayr; Franz A Zimmermann; Barbara Bogner; Wolfgang Sperl; Barbara Kofler
Journal:  Neuro Oncol       Date:  2015-06-23       Impact factor: 12.300

2.  Morphologic and molecular characteristics of uterine leiomyomas in hereditary leiomyomatosis and renal cancer (HLRCC) syndrome.

Authors:  Julian Sanz-Ortega; Cathy Vocke; Pamela Stratton; William Marston Linehan; Maria J Merino
Journal:  Am J Surg Pathol       Date:  2013-01       Impact factor: 6.394

Review 3.  Components of cancer metabolism and therapeutic interventions.

Authors:  John Singleterry; Annapoorna Sreedhar; Yunfeng Zhao
Journal:  Mitochondrion       Date:  2014-06-06       Impact factor: 4.160

4.  CHARACTERISTICS AND OUTCOMES OF METASTATIC SDHB AND SPORADIC PHEOCHROMOCYTOMA/PARAGANGLIOMA: AN NATIONAL INSTITUTES OF HEALTH STUDY.

Authors:  Hana Turkova; Tamara Prodanov; Marek Maly; Victoria Martucci; Karen Adams; Jiri Widimsky; Clara C Chen; Alexander Ling; Electron Kebebew; Constantine A Stratakis; Tito Fojo; Karel Pacak
Journal:  Endocr Pract       Date:  2015-11-02       Impact factor: 3.443

5.  Tumor hypoxia as a driving force in genetic instability.

Authors:  Kaisa R Luoto; Ramya Kumareswaran; Robert G Bristow
Journal:  Genome Integr       Date:  2013-10-24

6.  Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors.

Authors:  Attje S Hoekstra; Marieke A de Graaff; Inge H Briaire-de Bruijn; Cor Ras; Reza Maleki Seifar; Ivonne van Minderhout; Cees J Cornelisse; Pancras C W Hogendoorn; Martijn H Breuning; Johnny Suijker; Esther Korpershoek; Henricus P M Kunst; Norma Frizzell; Peter Devilee; Jean-Pierre Bayley; Judith V M G Bovée
Journal:  Oncotarget       Date:  2015-11-17

7.  The Impact Of Succinate Dehydrogenase Gene (SDH) Mutations In Renal Cell Carcinoma (RCC): A Systematic Review.

Authors:  Seyed Mohammad Kazem Aghamir; Ramin Heshmat; Mehdi Ebrahimi; Seyed Ebrahim Ketabchi; Somayeh Parichehreh Dizaji; Fatemeh Khatami
Journal:  Onco Targets Ther       Date:  2019-09-26       Impact factor: 4.147

Review 8.  Clinical implications of the oncometabolite succinate in SDHx-mutation carriers.

Authors:  Karin Eijkelenkamp; Thamara E Osinga; Thera P Links; Anouk N A van der Horst-Schrivers
Journal:  Clin Genet       Date:  2019-05-06       Impact factor: 4.438

Review 9.  Metabolic implications of hypoxia and pseudohypoxia in pheochromocytoma and paraganglioma.

Authors:  Katarina Kluckova; Daniel A Tennant
Journal:  Cell Tissue Res       Date:  2018-02-15       Impact factor: 5.249

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.